Owing to their high surface area, stability, and functional groups on the surface, iron oxide hydroxide nanoparticles have attracted attention as enzymatic support. In this work, a chemometric approach was performed, aiming at the optimization of the horseradish peroxidase (HRP) immobilization process on Δ-FeOOH nanoparticles (NPs). The enzyme/NPs ratio (X1), pH (X2), temperature (X3), and time (X4) were the independent variables analyzed, and immobilized enzyme activity was the response variable (Y). The effects of the factors were studied using a factorial design at two levels (−1 and 1). The biocatalyst obtained was evaluated for the ferulic acid (FA) removal, a pollutant model. The materials were characterized by X-ray powder diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). The SEM images indicated changes in material morphology. The independent variables X1 (−0.57), X2 (0.71), and X4 (0.42) presented the significance effects estimate. The variable combinations resulted in two significance effects estimates, X1*X2 (−0.57) and X2*X4 (0.39). The immobilized HRP by optimized conditions (X1 = 1/63 (enzyme/NPs ratio, X2 = pH 8, X4 = 60 °C, and 30 min) showed high efficiency for FA oxidation (82%).
The immobilization of enzymes is an excellent alternative to overcome the drawbacks of using these biocatalysts in free form. This process plays a significant role in cost-effective recovery, increased catalyst productivity and in simplifying process operations. After the soybean peroxidase (SP) extraction, a residue at high carbon and low ash content is generated. This residue was used as carbonaceous precursor for production of carbon activated (AC) with high surface area (1603 m2 g−1). The AC produced was used as support for SP immobilization. The immobilization of SP was evaluated in different time conditions, enzyme load, pH and temperature. The samples, before and after immobilization, were characterized by thermogravimetric analysis, elemental analysis composition, specific surface area, X-ray powder diffraction, scanning electron microscopy and Fourier transform infrared spectroscopy. In addition, repeated applications of immobilized biocatalyst were made in order to evaluate its operational stability and capacity to recover the reaction medium, in which was observed that after a decline in activity from the first to the second cycle, it remained constant until the tenth application. In the context, the process of material obtainment constitutes a clean route for the development of more sustainable biocatalysts capable of applications in various areas.
In this work we investigated the enzymatic degradation of ferulic acid, a model pollutant, by free and immobilized soybean peroxidase. With the aim of developing greener catalysts, we proposed the synthesis of a magnetic catalyst prepared via immobilization of soybean peroxidase onto a magnetic nanosupport by covalent attachment. The immobilization of soybean peroxidase was carried out using magnetite nanoparticles modified with amino groups as support. The magnetite particles were characterized before and after chemical modification by XRD, SEM and TEM analysis. The characterization data indicated that the Fe3O4–SiO2 nanoparticles were successfully synthetized. The high immobilization yield was obtained in only 1 hour of reaction (89.23%). The resulting nanobiocatalyst (enzyme load 5.25 U) was able to remove 99.67 ± 0.10% of ferulic acid in comparison to 57.67 ± 0.27% for free enzyme under the same reaction conditions. The immobilized peroxidase could easily be separated under a magnetic field and reused. On the basis of these results, we concluded that the prepared magnetic nanoparticles can be considered a high-performance nanocatalyst for environmental remediation.
6 October 2017 in Bioprocess and Biosystems Engineering
Olaparib is a potent poly (ADP-ribose) polymerase inhibitor currently used in targeted therapy for treating cancer cells with BRCA mutations. Here we investigate the possible interference of olaparib with daunorubicin (Daun) metabolism, mediated by carbonyl-reducing enzymes (CREs), which play a significant role in the resistance of cancer cells to anthracyclines. Incubation experiments with the most active recombinant CREs showed that olaparib is a potent inhibitor of the aldo–keto reductase 1C3 (AKR1C3) enzyme. Subsequent inhibitory assays in the AKR1C3-overexpressing cellular model transfected human colorectal carcinoma HCT116 cells, demonstrating that olaparib significantly inhibits AKR1C3 at the intracellular level. Consequently, molecular docking studies have supported these findings and identified the possible molecular background of the interaction. Drug combination experiments in HCT116, human liver carcinoma HepG2, and leukemic KG1α cell lines showed that this observed interaction can be exploited for the synergistic enhancement of Daun’s antiproliferative effect. Finally, we showed that olaparib had no significant effect on the mRNA expression of AKR1C3 in HepG2 and KG1α cells. In conclusion, our data demonstrate that olaparib interferes with anthracycline metabolism, and suggest that this phenomenon might be utilized for combating anthracycline resistance.